Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease
Eliana Barriocanal‐Casado, Agustín Hidalgo‐Gutiérrez, Nuno Raimundo, et al.
EBioMedicine (2019) Vol. 42, pp. 511-523
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Mitochondrial DNA copy number in human disease: the more the better?
Roberta Filograna, Mara Mennuni, David Alsina, et al.
FEBS Letters (2020) Vol. 595, Iss. 8, pp. 976-1002
Open Access | Times Cited: 355
Mitochondria–Lysosome Crosstalk: From Physiology to Neurodegeneration
Cláudia M. Deus, King Faisal Yambire, Paulo J. Oliveira, et al.
Trends in Molecular Medicine (2019) Vol. 26, Iss. 1, pp. 71-88
Open Access | Times Cited: 226
The Balance of MFN2 and OPA1 in Mitochondrial Dynamics, Cellular Homeostasis, and Disease
Paola Zanfardino, Alessandro Amati, M Perrone, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 433-433
Open Access | Times Cited: 1
Therapeutic Approaches to Treat Mitochondrial Diseases: “One-Size-Fits-All” and “Precision Medicine” Strategies
Emanuela Bottani, Costanza Lamperti, Alessandro Prigione, et al.
Pharmaceutics (2020) Vol. 12, Iss. 11, pp. 1083-1083
Open Access | Times Cited: 56
Moving towards clinical trials for mitochondrial diseases
Robert D. S. Pitceathly, Nandaki Keshavan, Joyeeta Rahman, et al.
Journal of Inherited Metabolic Disease (2020) Vol. 44, Iss. 1, pp. 22-41
Open Access | Times Cited: 53
Strategies for fighting mitochondrial diseases
Carlo Viscomi, Massimo Zeviani
Journal of Internal Medicine (2020) Vol. 287, Iss. 6, pp. 665-684
Open Access | Times Cited: 50
Bioenergetics and translational metabolism: implications for genetics, physiology and precision medicine
Bradford G. Hill, Sruti Shiva, Scott W. Ballinger, et al.
Biological Chemistry (2019) Vol. 401, Iss. 1, pp. 3-29
Open Access | Times Cited: 53
Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation
Chih-Yao Chung, Kritarth Singh, Vassilios N. Kotiadis, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Leigh Syndrome: A Study of 209 Patients at the Beijing Children's Hospital
Sarah L. Stenton, Ying Zou, Hua Cheng, et al.
Annals of Neurology (2022) Vol. 91, Iss. 4, pp. 466-482
Closed Access | Times Cited: 23
Evaluation of Candidate ″Kill or Cure″ Strategies to Treat MFN2-related Lipodystrophy
Ineke Luijten, Xiong Weng, Ula Kibildyte, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The therapeutic potential of a polyunsaturated fatty acid-enriched high-fat diet in Leigh syndrome: Insights from a preclinical model
Luciano Willemse, Karin Terburgh, Roan Louw
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 6, pp. 167873-167873
Open Access
Modulating mitochondrial DNA mutations: factors shaping heteroplasmy in the germ line and somatic cells
Marcos Roberto Chiaratti, Patrick F. Chinnery
Pharmacological Research (2022) Vol. 185, pp. 106466-106466
Open Access | Times Cited: 18
Biological and translational attributes of mitochondrial DNA copy number: Laboratory perspective to clinical relevance
Deepak Parchwani, Ragini Singh, Digisha Patel
World Journal of Methodology (2025) Vol. 15, Iss. 3
Closed Access
Rapamycin exerts neuroprotective effects by inhibiting FKBP12 instead of mTORC1 in the mouse model of Parkinson’s disease
Zeyan Zhang, Ziyue Shen, Shiming Xie, et al.
Neuropharmacology (2025), pp. 110504-110504
Closed Access
Mitochondrial disorders and drugs: what every physician should know
Daniele Orsucci, Elena Caldarazzo Ienco, Gabriele Siciliano, et al.
Drugs in Context (2019) Vol. 8, pp. 1-16
Open Access | Times Cited: 28
Rewiring cell signalling pathways in pathogenic mtDNA mutations
Chih-Yao Chung, Gabriel E. Valdebenito, Anitta R. Chacko, et al.
Trends in Cell Biology (2021) Vol. 32, Iss. 5, pp. 391-405
Open Access | Times Cited: 22
Interactions of mitochondrial and skeletal muscle biology in mitochondrial myopathy
Valeria Di Leo, Tiago Gomes, Amy E. Vincent
Biochemical Journal (2023) Vol. 480, Iss. 21, pp. 1767-1789
Open Access | Times Cited: 8
Coenzyme Q homeostasis in aging: Response to non-genetic interventions
Guillermo López‐Lluch
Free Radical Biology and Medicine (2021) Vol. 164, pp. 285-302
Open Access | Times Cited: 18
Advances in the treatment of mitochondrial epilepsies
Shamima Rahman
Epilepsy & Behavior (2019) Vol. 101, pp. 106546-106546
Open Access | Times Cited: 22
Up-regulation of cholesterol synthesis by lysosomal defects requires a functional mitochondrial respiratory chain
Francesco Agostini, Leonardo Pereyra, Justin Dale, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 7, pp. 107403-107403
Open Access | Times Cited: 2
Mitochondrial spongiotic brain disease: astrocytic stress and harmful rapamycin and ketosis effect
Olesia Ignatenko, Joni Nikkanen, Alexander Kononov, et al.
Life Science Alliance (2020) Vol. 3, Iss. 9, pp. e202000797-e202000797
Open Access | Times Cited: 17
β-RA Targets Mitochondrial Metabolism and Adipogenesis, Leading to Therapeutic Benefits against CoQ Deficiency and Age-Related Overweight
Agustín Hidalgo‐Gutiérrez, Eliana Barriocanal‐Casado, María Elena Díaz-Casado, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1457-1457
Open Access | Times Cited: 13
Experimental therapy for mitochondrial diseases
Carlo Viscomi, Massimo Zeviani
Handbook of clinical neurology (2023), pp. 259-277
Closed Access | Times Cited: 5
Animal Models of Coenzyme Q Deficiency: Mechanistic and Translational Learnings
Pilar González-García, Eliana Barriocanal‐Casado, María Elena Díaz-Casado, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1687-1687
Open Access | Times Cited: 12
The Q-junction and the inflammatory response are critical pathological and therapeutic factors in CoQ deficiency
Pilar González-García, María Elena Díaz-Casado, Agustín Hidalgo‐Gutiérrez, et al.
Redox Biology (2022) Vol. 55, pp. 102403-102403
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top